A phase I study of patients with head and neck cancers has shown that a cisplatin-albumin complex, either at a starting dose of 100 mg/m2 or a gradually escalated dose to 650 mg/m2, caused no significant nephrotoxicity or ototoxicity [36]. Here, ALB is linked to head and neck cancer.